Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILM Peeling-Reposition vs Peeling for Idiopathic Macular Holes
NCT03020459Completed
- Sponsor
- Xinhua Hospital
- Start
- Jan 2017
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Xinhua Hospital. Primary endpoint: Best Corrected Visual Acuity at 6 months. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03020459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020459.